1.
Kaltenbach K, Berghella V, Finnegan L. Opioid dependence during pregnancy. Effects and management. Obstet Gynecol Clin North Am 1998;25(1):139-51.
2.
Finnegan LP.
Treatment issues for opioid-dependent women during the perinatal period. J Psychoactive
Drugs 1991;23(2):191-201.
3.
Fitzsimmons
J, Tunis S, Webster D, Izes J, Wapner R, Finnegan L. Pregnancy in a drug-abusing
population. Am J Drug Alcohol Abuse 1986;12(3):247-55.
4.
Kaltenbach
K, Finnegan LP. Perinatal and developmental outcome of infants exposed to methadone
in-utero. NIDA Res Monogr 1987;76:276.
5.
Finnegan LP.
Management of pregnant drug-dependent women. Ann N Y Acad Sci 1978;311:135-46.
6.
Hoegerman G.
Narcotic Use in Pregnancy. Clinics in Perinatology 1991;18:51 - 76.
7.
Kreek MJ. Analysis
of methadone and other drugs in maternal and neonatal body fluids: use in evaluation
of symptoms in a neonate of
mother maintained on methadone. American Journal
Drug Alcohol Abuse 1974;1:409 - 19.
8.
Wittmann M.
A comparison of the effects of single- and split-dose methadone administration on
the fetus: Ultrasound evaluation. International Journal of Addictions 1991;26:213-18.
9.
Pond SM, Kreek
MJ, Tong TG, Raghunath J, Benowitz NL. Altered methadone pharmacokinetics in methadone-maintained
pregnant women. Journal of Pharmacology and Experimental Therapeutics 1985;233:1-6.
10.
Kreek MJ. Methadone disposition during the
perinatal period in humans. Pharm Biochem Beh 1979;11:7-13.
11.
Wang EC. Methadone treatment during pregnancy.
Journal of Obstetric, Gynecologic, & Neonatal Nursing 1999;28(6):615-22.
12.
Marquet P, Chevrel J, Lavignasse P, Merle
L, Lachatre G. Buprenorphine withdrawal syndrome in a newborn. Clin Pharmacol Ther
1997;62(5):569-71.
13.
Pani P, Maremmani I, Pirastu R, Tagliamonte
A, Gessa G. Buprenorphine: a controlled clinical trial in the treatment of opioid
dependence. Drug and Alcohol Dependence 2000;60(Jul 1):39-50.
14.
Fischer G, Gombas W, Eder H, Jagsch R, Peternell
A, Stuhlinger G, et al. Buprenorphine versus methadone maintenance for the treatment
of opioid dependence. Addiction 1999;94(Sep):1337-47.
15.
Williams A.When the client is pregnant: information
for counselors. J Subst Abuse Treat 1985;2(1):27-34.
16.
Finnegan LP. Neonatal abstinence syndrome:
assessment and pharmacotherapy. N.Y.: Exerpta Medica; 1986.
17.
Committee on Drugs AAoP. Neonatal Drug Withdrawal.
Pediatrics 1998;101(No. 6):1079 - 88.
18.
McCarthy JJ, Posey BL. Methadone levels in
human milk. J Human Lactation 2000;16(2):115-20.
19.
Silver H, Wapner R, Loriz-Vega M, Finnegan
LP. Addiction in pregnancy: high risk intrapartum management and outcome. J Perinatol
1987;7(3):178-84.
20.
Mack G. Methadone levels and neonatal withdrawal.
J. Pediatr Child Health 1991;27:96 - 100.
21.
Rosen TS. Disposition of methadone and its
relationship to severity of withdrawal in the newborn. Addict. Dis. 1975;2:169 -78.
22.
Doberczak TM, Kandall SR, Friedmann P. Relationship
between maternal methadone dosage, maternal-neonatal methadone levels, and neonatal
withdrawal. Obstet Gynecol 1993;81(6):936-40.
23.
Rosen RS. Pharmacologic Observation on the
neonatal withdrawal syndrome. J. Pediatrics 1976;89:1004 - 48.
24.
Lipsitz PJ. A proposed narcotic withdrawal
score for use with newborn infants. A pragmatic evaluation of its efficacy. Clin.
Pediatr. 1975;14:592 - 94.
25.
Ostrea EM. Infants of drug dependent-mothers.
Philadelphia
: WB Saunders; 1993.
26.
Martinez
A, Kastner B, Taeusch HW. Hyperphagia in neonates withdrawing from methadone. Archives
of Disease in Childhood Fetal & Neonatal Edition 1999;80(3).
27.
D'Apolito K. Comparison of a rocking bed
and standard bed for decreasing withdrawal symptoms in drug-exposed infants. Journal
of Maternal Child Nursing 1999:138-44.
28.
Finnegan LP, Mitros TF, Hopkins LE. Management
of neonatal narcotic abstinence utilizing a phenobarbital loading dose method. NIDA
Res Monogr 1979;27:247-53.
29.
Hoder EL, Leckman JF, Poulsen J, Caruso KA,
Ehrenkranz RA, Kleber HD, et al. Clonidine treatment of neonatal narcotic abstinence
syndrome. Psychiatry Res 1984;13(3):243-51.
30.
Malpas TJ, Darlow BA. Neonatal abstinence
syndrome following abrupt cessation of breastfeeding. N Z Med J 1999;112(1080):12-3.
31.
Atkinson HC. Prediction of drug distribution
intohuman milk from physiochemical characteristics. Clinical Pharmacokinetics 1990;18:151.
32.
Lawrence
RA. Breastfeeding. fifth ed.
St. Louis
: Mosby; 1999.
33.
Geraghty B, Graham EA, Logan B, Weiss EL.
Methadone levels in breast milk. J Hum Lact 1997;13(3):227-30.
34.
Blinick G, Inturriel CE,
Jerez
B, Wallace RC. Methadone assays in pregnant women and progeny. Am. J. Obstet.Gynecol.
1975;121:617-21.
35. Jones H. Shorter dosing interval of opiate solution shortens
hospital stay
for methadone babies. Family Medicine 1999;31(May):327-30.